Literature DB >> 21394463

Inflammatory bowel disease characteristics and treatment in Hispanics and Caucasians.

Jason Hou1, Hashem El-Serag, Joseph Sellin, Selvi Thirumurthi.   

Abstract

BACKGROUND: Many inflammatory bowel disease (IBD) studies have focused on Caucasian patients and little data exist on IBD in Hispanics living in the United States. AIM: The aim of our study was to compare IBD characteristics between Hispanic and Caucasian patients in the Harris County Hospital District (HCHD).
METHODS: We identified patients within the HCHD with a diagnosis of Crohn's disease (CD) or ulcerative colitis (UC) recorded during 2000-2006. Primary medical record review was performed to confirm the diagnosis and to abstract data on patient demographics, disease characteristics and treatment.
RESULTS: A total of 69 Hispanic and 83 Caucasian patients with confirmed IBD were analyzed. Hispanics were diagnosed with IBD at an older age than Caucasians (mean age 37.8 SD 16 vs. mean age 29.0 SD 14, P < 0.01). In Hispanics with IBD, there was a lower proportion of patients with CD compared to Caucasians with IBD (36% vs. 65%, P < 0.01). Although there were no significant differences in diagnostic examinations or medication prescription between the two groups, there was a higher number of bowel resections per patient in Caucasians compared with Hispanics (0.5 vs. 0.22, P = 0.01).
CONCLUSIONS: Hispanics with IBD were diagnosed at a significantly older age than Caucasians and had a lower number of bowel resections per patient. In Hispanics with IBD, UC was more common than CD while CD was more common than UC among Caucasians with IBD. Further research is required to confirm these observations and determine if these findings reflect genetic or environmental differences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21394463     DOI: 10.1007/s10620-011-1629-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Basic epidemiology of inflammatory bowel disease in Puerto Rico.

Authors:  Caroline B Appleyard; Gerardo Hernández; Carlos F Rios-Bedoya
Journal:  Inflamm Bowel Dis       Date:  2004-03       Impact factor: 5.325

2.  Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.

Authors:  Edward V Loftus
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

Review 3.  Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review.

Authors:  Jason K Hou; Hashem El-Serag; Selvi Thirumurthi
Journal:  Am J Gastroenterol       Date:  2009-05-26       Impact factor: 10.864

4.  Crohn's disease among ethnic groups in a large health maintenance organization.

Authors:  J H Kurata; S Kantor-Fish; H Frankl; P Godby; C M Vadheim
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

5.  Effect of race and ethnicity on perceptions of inflammatory bowel disease.

Authors:  Darrell G Finlay; Dhiman Basu; Joseph H Sellin
Journal:  Inflamm Bowel Dis       Date:  2006-06       Impact factor: 5.325

6.  Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.

Authors:  Ida Vind; Lene Riis; Tine Jess; Elisabeth Knudsen; Natalia Pedersen; Margarita Elkjaer; Inger Bak Andersen; Vibeke Wewer; Peter Nørregaard; Flemming Moesgaard; Flemming Bendtsen; Pia Munkholm
Journal:  Am J Gastroenterol       Date:  2006-06       Impact factor: 10.864

7.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

8.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

9.  Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.

Authors:  Esther A Torres; Ramón De Jesús; Cynthia M Pérez; Michael Iñesta; Daniel Torres; Carlos Morell; Erica Just
Journal:  P R Health Sci J       Date:  2003-09       Impact factor: 0.705

10.  Infliximab maintenance therapy for fistulizing Crohn's disease.

Authors:  Bruce E Sands; Frank H Anderson; Charles N Bernstein; William Y Chey; Brian G Feagan; Richard N Fedorak; Michael A Kamm; Joshua R Korzenik; Bret A Lashner; Jane E Onken; Daniel Rachmilewitz; Paul Rutgeerts; Gary Wild; Douglas C Wolf; Paul A Marsters; Suzanne B Travers; Marion A Blank; Sander J van Deventer
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

View more
  5 in total

1.  Radiation exposure from diagnostic imaging studies among patients with inflammatory bowel disease in a safety-net health-care system.

Authors:  Jason K Hou; Hoda M Malaty; Selvi Thirumurthi
Journal:  Dig Dis Sci       Date:  2013-09-12       Impact factor: 3.199

2.  Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.

Authors:  Mimi C Tan; Hashem B El-Serag; Jason K Hou
Journal:  Dig Dis Sci       Date:  2016-12-23       Impact factor: 3.199

Review 3.  Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis.

Authors:  Danny J Avalos; Antonio Mendoza-Ladd; Marc J Zuckerman; Mohammad Bashashati; Andres Alvarado; Alok Dwivedi; Oriana M Damas
Journal:  Dig Dis Sci       Date:  2018-03-29       Impact factor: 3.199

4.  Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay.

Authors:  Edward L Barnes; Bharati Kochar; Millie D Long; Christopher F Martin; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2017-12       Impact factor: 7.290

5.  Predictors of High Health Care Utilization in Patients With Inflammatory Bowel Disease Within 1 Year of Establishing Specialist Care.

Authors:  Kenechukwu Chudy-Onwugaje; Alexander P Mamunes; David A Schwartz; Sara Horst; Raymond K Cross
Journal:  Inflamm Bowel Dis       Date:  2021-02-16       Impact factor: 5.325

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.